![Fang Liang Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fang Liang Zhang
Presidente en LEGEND BIOTECH CORPORATION .
Fortuna: 280 M $ al 31/10/2024
Perfil
Fang Liang Zhang is the founder of GenScript Corp.
(founded in 2002) and Genscript Biotech Corp.
(founded in 2002).
He currently holds the position of Chairman at Legend Biotech Corp.
and Director at GenScript (Hong Kong) Ltd.
He is also an Executive Director at Genscript Biotech Corp.
and holds director positions at Nanjing Jinsirui Biotechnology Co., Ltd., Jinsikang Technology (Nanjing) Co., Ltd., Nanjing Bestzyme Bioengineering Co., Ltd., Hubei Bestzyme Biotechnology Co. Ltd., Shanghai Jingrui Biotechnology Co. Ltd., Bestzyme Biotech Corp., Bestzyme Biotech Hk Ltd., Bestzyme Biotech Ltd., Bestzyme Biotech USA, Inc., Nanjing Legend Biotech Co., Ltd., Legend Biotech HK Ltd., Legend Biotech Ltd., Genscript Biotech Ltd., GenScript International Ltd., and GenScript USA, Inc. His former positions include Chairman & Chief Executive Officer at Nanjingjinsirui Science & Technology Biology Corp., Director at Legend Biotech Corp.
(2020), and Principal Scientist at Schering-Plough Holdings Ltd.
(2002).
Dr. Zhang obtained a doctorate degree from Duke University in 1995, a graduate degree from Nanjing University in 1987, and an undergraduate degree from Chengdu University of Technology in 1984.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/11/2024 | 167 462 745 ( 7.87% ) | 256 M $ | 31/10/2024 | |
LEGEND BIOTECH CORP.
0.37% | 31/12/2023 | 1 067 386 ( 0.37% ) | 24 M $ | 31/10/2024 |
Cargos activos de Fang Liang Zhang
| Empresas | Cargo | Inicio |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Miembro de la Junta | 02/05/2022 |
| LEGEND BIOTECH CORPORATION | Presidente | 02/08/2022 |
| Bestzyme Biotech Hk Ltd. | Director/Miembro de la Junta | - |
GenScript USA, Inc.
 GenScript USA, Inc. Medical SpecialtiesHealth Technology GenScript USA, Inc. engages in the provision of life science research services. The company is headquartered in United States. | Director/Miembro de la Junta | - |
| GenScript International Ltd. | Director/Miembro de la Junta | - |
GenScript (Hong Kong) Ltd.
 GenScript (Hong Kong) Ltd. Medical/Nursing ServicesHealth Services Part of Genscript Biotech Corp., GenScript (Hong Kong) Ltd. provides diagnostic services for medical professionals. The company is based in Hong Kong, Hong Kong. | Director/Miembro de la Junta | - |
| Genscript Biotech Ltd. | Director/Miembro de la Junta | 02/05/2022 |
| Legend Biotech Ltd. | Director/Miembro de la Junta | - |
| Legend Biotech HK Ltd. | Director/Miembro de la Junta | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Antiguos cargos conocidos de Fang Liang Zhang.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Formación de Fang Liang Zhang.
| Chengdu University of Technology | Undergraduate Degree |
| Nanjing University | Graduate Degree |
| Duke University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| Empresas privadas | 19 |
|---|---|
Nanjingjinsirui Science & Technology Biology Corp.
 Nanjingjinsirui Science & Technology Biology Corp. BiotechnologyHealth Technology Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China. | Health Technology |
| Bestzyme Biotech Corp. | |
Schering-Plough Holdings Ltd.
 Schering-Plough Holdings Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Holdings Ltd. develops and manufactures pharmaceutical products. It offers sterilization tablets, cotton buds, and animal & veterinary health products. The company is headquartered in Welwyn Garden City, UK. | Health Technology |
GenScript Corp.
 GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Health Technology |
| Nanjing Jinsirui Biotechnology Co., Ltd. | |
| Jinsikang Technology (Nanjing) Co., Ltd. | |
Nanjing Bestzyme Bioengineering Co., Ltd.
 Nanjing Bestzyme Bioengineering Co., Ltd. BiotechnologyHealth Technology Nanjing Bestzyme Bioengineering Co., Ltd. provides biological research and drug discovery services to pharmaceutical companies. The joint venture company is based in Nanjing, China. and has subsidiaries in China. | Health Technology |
| Hubei Bestzyme Biotechnology Co. Ltd. | |
| Shanghai Jingrui Biotechnology Co. Ltd. | |
| Bestzyme Biotech Ltd. | |
| Bestzyme Biotech Hk Ltd. | |
| Bestzyme Biotech USA, Inc. | |
Nanjing Legend Biotech Co., Ltd.
 Nanjing Legend Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Genscript Biotech Corp., Nanjing Legend Biotech Co., Ltd. is a commercial-stage biotechnology company that develops, manufactures, and commercializes novel therapies. Nanjing Legend Biotech Co., Ltd. is based in Nanjing, China. Nanjing Legend Biotech is fiercely pursuing and delivering therapies, creating new hope and new opportunities, and transforming the world of oncology and medicine. Nanjing Legend Biotech is dedicated to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, particularly hematological malignancies and solid tumors. The Chinese company is currently focused on discovering and developing a broad portfolio of cell therapies to strengthen patients' immune systems and fight diseases. The company's pipeline includes innovative technologies such as autologous chimeric antigen receptor T-cell therapy (CAR-T), allogeneic non-gene-editing CAR-T, natural killer (NK) cells, and CAR-?? T cells. | Commercial Services |
| Legend Biotech HK Ltd. | |
| Legend Biotech Ltd. | |
| Genscript Biotech Ltd. | |
GenScript (Hong Kong) Ltd.
GenScript (Hong Kong) Ltd. Medical/Nursing ServicesHealth Services Part of Genscript Biotech Corp., GenScript (Hong Kong) Ltd. provides diagnostic services for medical professionals. The company is based in Hong Kong, Hong Kong. | Health Services |
| GenScript International Ltd. | |
GenScript USA, Inc.
GenScript USA, Inc. Medical SpecialtiesHealth Technology GenScript USA, Inc. engages in the provision of life science research services. The company is headquartered in United States. | Health Technology |
- Bolsa de valores
- Insiders
- Fang Liang Zhang
